ArticleCureus2026

Safety and Tolerability of Vildagliptin 100 mg Sustained-Release Formulation in Type 2 Diabetes Mellitus: Results From a Prospective, Multicenter, Single-Arm, Post-marketing Surveillance Study.

Pravin Soni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.